{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:06:29Z","timestamp":1785855989234,"version":"3.56.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2023-KH137444"],"award-info":[{"award-number":["RS-2023-KH137444"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.diabet.2024.101581","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T22:54:37Z","timestamp":1727564077000},"page":"101581","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase IV inhibitors and risk of dementia among patients with type 2 diabetes and comorbid mental disorders: A population-based cohort study"],"prefix":"10.1016","volume":"50","author":[{"given":"Bin","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyesung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahhyung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Keon","family":"Yon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-7525","authenticated-orcid":false,"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2024.101581_bib0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019","volume":"9","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.diabet.2024.101581_bib0002","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2215-0366(23)00193-1","article-title":"Age of onset and cumulative risk of mental disorders: a cross-national analysis of population surveys from 29 countries","volume":"10","author":"McGrath","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.diabet.2024.101581_bib0003","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jamapsychiatry.2021.4377","article-title":"Longitudinal associations of mental disorders with Dementia: 30-year analysis of 1.7 million New Zealand citizens","volume":"79","author":"Richmond-Rakerd","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.diabet.2024.101581_bib0004","doi-asserted-by":"crossref","first-page":"729","DOI":"10.7326\/M15-0381","article-title":"The burden of health care costs for patients with dementia in the last 5 years of life","volume":"163","author":"Kelley","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabet.2024.101581_bib0005","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00125-021-05609-x","article-title":"Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews","volume":"65","author":"Lindekilde","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2024.101581_bib0006","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/2230-8210.85579","article-title":"Diabetes and psychiatric disorders","volume":"15","author":"Balhara","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.diabet.2024.101581_bib0007","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/jamapsychiatry.2015.0082","article-title":"Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study","volume":"72","author":"Katon","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.diabet.2024.101581_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106062","article-title":"Cognitive impairment and type 2 diabetes mellitus: focus of SGLT2 inhibitors treatment","volume":"176","author":"Rizzo","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.diabet.2024.101581_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102018","article-title":"Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways","volume":"90","author":"Mancinetti","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.diabet.2024.101581_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-014-0148-1","article-title":"Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice","volume":"13","author":"Lin","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2024.101581_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105158","article-title":"Empagliflozin nanoparticles attenuates type2 diabetes induced cognitive impairment via oxidative stress and inflammatory pathway in high fructose diet induced hyperglycemic mice","volume":"150","author":"Khan","year":"2021","journal-title":"Neurochem Int"},{"key":"10.1016\/j.diabet.2024.101581_bib0012","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/bab.1319","article-title":"Forxiga (dapagliflozin): plausible role in the treatment of diabetes-associated neurological disorders","volume":"63","author":"Shaikh","year":"2016","journal-title":"Biotechnol Appl Biochem"},{"key":"10.1016\/j.diabet.2024.101581_bib0013","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13195-020-00607-4","article-title":"Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes","volume":"12","author":"Hierro-Bujalance","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.diabet.2024.101581_bib0014","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2337\/dc22-1705","article-title":"Association of sodium-glucose cotransporter 2 inhibitors with time to Dementia: a population-based cohort study","volume":"46","author":"Wu","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2024.101581_bib0015","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4093\/dmj.2022.0193","article-title":"Current trends of big data research using the Korean national health information database","volume":"46","author":"Kim","year":"2022","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabet.2024.101581_bib0016","unstructured":"Statistics korea. https:\/\/kostatgokr\/anse Accessed on March 22, 2023."},{"key":"10.1016\/j.diabet.2024.101581_bib0017","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00125-021-05393-8","article-title":"Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled carolina-cognitioN study","volume":"64","author":"Biessels","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2024.101581_bib0018","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2337\/dc19-0783","article-title":"Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the carmelina randomized trial","volume":"42","author":"Biessels","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2024.101581_bib0019","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S2215-0366(20)30421-1","article-title":"Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study","volume":"7","author":"Lee","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.diabet.2024.101581_bib0020","doi-asserted-by":"crossref","first-page":"m853","DOI":"10.1136\/bmj.m853","article-title":"Association between maternal and paternal mental illness and risk of injuries in children and adolescents: nationwide register based cohort study in Sweden","volume":"369","author":"Nevriana","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.diabet.2024.101581_bib0021","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/HYPERTENSIONAHA.119.14388","article-title":"Blood Pressure control and dementia risk in midlife patients with atrial fibrillation","volume":"75","author":"Kim","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.diabet.2024.101581_bib0022","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.diabet.2024.101581_bib0023","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.diabet.2024.101581_bib0024","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the lancet commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2024.101581_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/14791641221098168","article-title":"The association between sodium-glucose cotransporter 2 inhibitors and incident dementia: a nationwide population-based longitudinal cohort study","volume":"19","author":"Siao","year":"2022","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.diabet.2024.101581_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.747620","article-title":"Sodium-glucose cotransporter 2 (SGLT2) inhibitors vs. Dipeptidyl peptidase-4 (DPP4) inhibitors for new-onset dementia: a propensity score-matched population-based study with competing risk analysis","volume":"8","author":"Mui","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.diabet.2024.101581_bib0027","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-014-0148-1","article-title":"Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice","volume":"13","author":"Lin","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2024.101581_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105158","article-title":"Empagliflozin nanoparticles attenuates type2 diabetes induced cognitive impairment via oxidative stress and inflammatory pathway in high fructose diet induced hyperglycemic mice","volume":"150","author":"Khan","year":"2021","journal-title":"Neurochem Int"},{"key":"10.1016\/j.diabet.2024.101581_bib0029","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.diabet.2024.101581_bib0030","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2174\/1871527315666161003125752","article-title":"Prediction of anti-diabetic drugs as dual inhibitors against acetylcholinesterase and beta-secretase: a neuroinformatics study","volume":"15","author":"Shaikh","year":"2016","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.diabet.2024.101581_bib0031","first-page":"121","article-title":"Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: focus on fat browning and macrophage polarization","volume":"7","author":"Xu","year":"2018","journal-title":"Adipocyte"},{"key":"10.1016\/j.diabet.2024.101581_bib0032","first-page":"10","article-title":"Obesity is now the top modifiable dementia risk factor in the US","volume":"328","author":"Slomski","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.diabet.2024.101581_bib0033","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/oby.23331","article-title":"SGLT inhibitors on weight and body mass: a meta-analysis of 116 randomized-controlled trials","volume":"30","author":"Cheong","year":"2022","journal-title":"Obesity"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363624000739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363624000739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T07:25:47Z","timestamp":1734679547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363624000739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1262363624000739"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2024.101581","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase IV inhibitors and risk of dementia among patients with type 2 diabetes and comorbid mental disorders: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2024.101581","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101581"}}